Clinical Microbiology: Bugs & Drugs

Fosfomycin susceptibility testing is a challenge for laboratories. The testing intricacies for fosfomycin are discussed.
Monday, 06 November 2017 18:17

Considerations in point-of-care diagnostics

Written by
How will point-of-care diagnostics change clinical microbiology? ASM provides resources with educational opportunities and important considerations on implementing evolving technology.
ASM provides resources to review nomenclature, susceptibilty testing, and transmission prevention of multidrug-resistant organisms
Monday, 23 October 2017 11:51

Point-of-Care Testing for Influenza

Written by
“Do I have the flu?” Influenza point of care tests may be able to answer this question quickly. However, despite the simplicity and speed of these tests, they come with many “behind the scenes” considerations to be addressed prior to implementation. In this post, we review some significant technical, biological, and regulatory issues of influenza point-of-care testing.
Blood draw done without the gloves on is poor technique. Noncompliance to proper disinfection techniques of the draw site is the primary reason for blood culture contamination. Today's Bugs & Drugs post highlights the importance of updating staff on the whys and hows of preventing this contamination.
Monday, 09 October 2017 10:34

Non-culture based fungal diagnostic tests

Written by
Timely diagnosis of fungal infections is sometimes impaired by the slow growth in culture or low yield of culture for certain organisms. Let’s discuss some of the non-culture based fungal diagnostic tests that are available in clinical microbiology laboratories.
Monday, 02 October 2017 15:40

The importance of antiseptics

Written by
Antiseptics are found in both home and healthcare facilities and play an important role in infection prevention. We highlight a recent Applied and Environmental Microbiology study suggesting home use of antiseptics may contribute to MRSA spread and provide resources to review the mechanisms and applications of different chemical antiseptics.
Molecular techniques allow us to determine bacterial relatedness in ways previous generations couldn’t, and because of this, several species have been renamed or recategorized in recent years. However, this can cause chaos and miscommunication in the clinical lab! Here are three stories of recent taxonomical change suggestions and how they have been resolved.  
Anaerobic infections offer a unique set of challenges in diagnosing and antibiotic susceptibility testing. The most recent Hot Topic in Clinical Microbiology offers an opportunity to learn best practices in diagnosis of anaerobic infections. We also provide recent Journal of Clinical Microbiology resources to complement the presentation. 
While Lyme disease is the tick-borne illness people associate most readily with deer tick bites, the incidence of Babesia microti in the Northeast US has been increasing steadily. There are a range of tools, some new but many old, that can aid the diagnostician in detection of this important pathogen.
Taxonomic splitting of bacterial species can change AST recommendation. What should clinical microbiologists do when new species are assigned to the Enterobacteriaceae or when species are renamed? Romney Humphries addresses this problem in this week's Bugs & Drugs.
Recent outbreaks in clinical and teaching microbiology labs emphasize the importance of good biosafety practices. This week we provide resources to help brush up on biosafety, one of the most important aspects of working in a microbiology lab.
The Journal of Clinical Microbiology publishes everything clinical, from applications of new diagnostic technologies to global epidemiological reports. On this week's Bugs & Drugs, we spoke with JCM Editor-in-Chief Alexander McAdam about the resources JCM provides to clinical microbiologists and recent changes in the journal.  
Monday, 07 August 2017 14:45

Have Microscope … Will Travel

Written by
Interested in applying your laboratory skills in resource-limited areas? Volunteer work can be very fulfilling. Opportunities and experiences are discussed in this week's Bugs & Drugs.
How does one interpret an MIC if there is no clinical breakpoint for the tested drug/bug combination? Some tools, including the epidemiological cut-off value and PK/PD breakpoints can help!
When laboratories provide susceptibility reports to clinicians, they must decide whether to include minimal inhibitory concentrations (MICs) or to report categorical interpretations (such as susceptible or resistant) alone. In some cases knowing the MIC value can help doctors, but in other cases it may just be… TMI.
Summertime brings people closer to the great outdoors - and to arthropods that can spread disease! In this week's Bugs & Drugs, we emphasize the importance of a full patient history and provide resources on infections of leisure.
Bloodstream infections are a major cause of morbidity and mortality, and identifying the causative organism(s) is critical. Can the most important step in this process really be as simple as collecting enough volume of blood for culture? Let’s discuss some of the evidence, and the role of the clinical microbiology laboratory in this important testing process.
Several of the American Society for Clinical Pathology's "40 Under Forty"  include young, successful ASM members, and we here at Bugs & Drugs reached out to ask them about their research and careers. 
Monday, 26 June 2017 09:33

C. difficile—Innocent until Proven Guilty?

Written by
Accurate diagnosis of Clostridium difficile infection (CDI) is challenging for all involved—clinicians, laboratorians, and patients—leaving everyone frustrated.  Current approaches to diagnosis of CDI prioritize either detection of the organism itself, or detection of toxins produced by the organism.  In this blog post, Nira Pollock explores how these diagnostic strategies differ in approach and perspective regarding the guilt of the suspect—should C. difficile be considered “innocent until proven guilty,” or “guilty until proven innocent”?
Page 1 of 2

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

4